UK NICE · October 24, 2025

NICE recommends new life-extending drug combination for advanced prostate cancer

Original title: Up to 6,000 people set to benefit after NICE recommends new life-extending drug for advanced prostate cancer

NICE recommends a new treatment combination for metastatic prostate cancer, enabling access in England from 24 October.

Low obligation Product class Pharmaceuticals Market Access & Reimbursement UK PharmaceuticalsReimbursement

People living with metastatic prostate cancer in England will gain access to a new treatment combination from today (Friday, 24 October), following a recommendation by NICE.

Dates and deadlines

Applies from

2024-10-24

Read the official source ↗

Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.